<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0038">
 <label>38</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Raje</surname>
    <given-names>N</given-names>
   </string-name>, 
   <string-name>
    <surname>Kumar</surname>
    <given-names>S</given-names>
   </string-name>, 
   <string-name>
    <surname>Hideshima</surname>
    <given-names>T</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma</article-title>. 
  <source>Blood</source>
  <year>2005</year>;
  <volume>106</volume>:
  <fpage>1042</fpage>–
  <lpage>7</lpage>.
  <pub-id pub-id-type="pmid">15827128</pub-id>
 </mixed-citation>
</ref>
